What is Medpace's business focus and history?
Medpace Holdings, Inc. is a publicly traded company based in Cincinnati, Ohio (United States), founded in 1992 by August J. Troendle. It operates as a full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. Medpace has raised $172.5 million in funding through its IPO in August 2016. The company employs approximately 6,200 people across 46 countries. Its top competitors include companies like ICON plc, Parexel, PPD, and Covance.
Medpace Corporate Details & Core Services
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries.
Medpace Contact Information & Official Links
What are Medpace's Key Business Metrics & Stats?
No of employees 6200
Founded year 1992
Type public
SAICS CODE 8731
NAICS Code 541715
Industry Clinical Research
Location Cincinnati, Ohio, United States
Stock Name MEDP (NASDAQ)
Pricing Strategy Custom pricing based on project scope
Medpace
MEDP (NASDAQ)
Firmographic Snapshot
2026
1992
Founded Year
6200
Global Employees
United States
Headquarters
Clinical Research Industry
Public
Type
Verified by
DexterAgent.ai
How much funding has Medpace raised to date?
Name
Description
Funding Amount
USD 172.5 Million
Stage
IPO
Latest Valuation
16.8 Billion (USD)
Investors
Public Investors
What are Medpace's Core Products?
Name
Description
Clinical Trial Management
Comprehensive management of Phase I-IV clinical trials, including study design, protocol development, and site management.
Central Laboratory Services
Integrated central lab services providing safety and efficacy testing, biomarker analysis, and biorepository services.
Bioanalytical Laboratory Services
Specialized bioanalytical testing for pharmacokinetics, pharmacodynamics, and immunogenicity assessments.
Imaging Core Lab
Advanced imaging services supporting clinical trials with standardized image acquisition and analysis.
What are the latest developments at Medpace?
Date
Type
Description
February, 2026
Financial Report
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results
What industry awards and recognitions has Medpace received?
Date
Type
Description
October, 2025
Industry Recognition
SCRS 2025 CRO Eagle Award
Medpace VS ICON plc VS Parexel VS PPD VS Covance : 2026 Comparison
Feature
Medpace
ICON plc
Parexel
PPD
Covance
Core Strengths Clinical Trial Management, Central Laboratory Services, Bioanalytical Laboratory Services, Imaging Core Lab
Clinical & Scientific Operations, Decentralised Clinical Trials, Laboratory Solutions
Clinical Trial Management, Regulatory Consulting, Real World Evidence, Medical Communications
Clinical Development Services, Laboratory Services, Functional Service Partnerships
Xcellerate Monitoring
Founded Year 1992
1990
1982
1985
1968
Stock Name/Ticker MEDP (NASDAQ)
ICLR (NASDAQ)
LH (NYSE)
Type public
public
private
private
public
Global Employees 6200
41900
24000
40000
15500
Revenue (Annual) $2.5 Billion(2025)
$8.3 Billion(2024)
$2.3 Billion(2017)
$4.7 Billion(2020)
$8.5 Billion(2014)
Headquarters Cincinnati, Ohio, United States
Dublin, Ireland
Raleigh, North Carolina, United States
Waltham, Massachusetts, United States
Durham, North Carolina, United States
Latest Valuation $16.8 Billion
$20.4 Billion
$8.5 Billion
$17.4 Billion
$0
LATEST REVENUE (TRILLIONS USD)
EMPLOYEE COUNT (THOUSANDS)
INNOVATORS
VISIONARIES
DISRUPTORS
GIANTS
ICON plc
8.3 | 41900
Parexel
2.3 | 24000
PPD
4.7 | 40000
Covance
8.5 | 15500
Competitive Landscape 2026
DexterAgent.ai
What are Medpace's official legal and registration details?
Name
Description
Legal Name
Medpace Holdings, Inc.
Cin number
GST number
Registration number
000000000
Who is in Medpace's executive leadership team?
Name
Designation
CEO
August J. Troendle
Where are Medpace's primary office locations?
City
Country
Cincinnati
United States
Dallas
United States
Denver
United States
Mexico City
Mexico
Tokyo
Japan
Beijing
China
Singapore
Singapore
Seoul
South Korea
Taipei
Taiwan
Sydney
Australia
Brussels
Belgium
London
United Kingdom
What are the current business signals and market intelligence for Medpace?
Spending next 3 months
Clinical trial expansion, Technology infrastructure, Global office expansion
Pain points
Complex regulatory requirements, Patient recruitment challenges, Data management complexities
Sales motion
Direct sales to biotech and pharma companies, Partnerships with medical device firms
Buyer Persona
Clinical Operations Managers, Regulatory Affairs Directors, R&D Executives
Type of customer
Biotechnology companies, Pharmaceutical companies, Medical device companies
Key customer domain
biogen.com, pfizer.com, medtronic.com
Annual ACV
$1M - $10M
What is Medpace's annual revenue history?
Year
Revenue (USD)
2025
2.5 Billion
What are Medpace's risk management and compliance ratings?
GDPR RIsk
Yes
Privacy Risk
Yes
Company Ratings
4
Glassdoor Rating
3.8
Saas
No
Offline Stores
No
Service
Yes
Ecommerce
No
Exporter
Yes
Mobile App
No
Retail
No
B2B
Yes
B2C
No
Manufacturing
No
Wholesale
No
Importer
No
